Company intelligence / Profile preview

Nanosyn

Santa Clara, California, United Statesnanosyn.com ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

Nanosyn specialized in miniaturized combinatorial chemistry, high-throughput screening, and small-batch manufacturing of active pharmaceutical ingredients (APIs), serving pharma, biotech, and academic clients. The company was recognized for innovative solutions that accelerated drug discovery through cost-efficient synthesis of diverse chemical libraries. It was acquired by Element Materials Technology.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Notable partnerships with small/mid-sized pharma/biotech companies and Top 50 Pharma companiesSynthorx cited as a satisfied partner/client

Beyond the preview

Go deeper on Nanosyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanosyn.